mtDam Cancer Research Results
mtDam, mitochondrial damage: Click to Expand ⟱
| Source: |
| Type: |
Mitochondrial damage can lead to a shift from oxidative phosphorylation to glycolysis, a process known as the Warburg effect. This shift can provide cancer cells with a selective advantage, allowing them to grow and proliferate more rapidly.
Mitochondrial Damage can also lead to cell death of cancer cells.
|
BC, Breast Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
GRP78/BiP↑, ER Stress↑, ROS↑, mtDam↑,
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Nor, |
HDFa |
|
|
|
*antiOx↑, *cardioP↑, *neuroP↑, selectivity↑, selectivity↓, TumCCA↑, ROS↑, mtDam↑,
| - |
Review, |
BC, |
MCF7 |
|
|
|
- |
Review, |
BC, |
MDA-MB-231 |
|
|
|
HER2/EBBR2↓, EGFR↓, mtDam↑, ROS↑, PI3K/Akt↓, P53↑, P21↑, Casp3↑, Casp9↑, BAX↑, PTEN↑, Bcl-2↓, hTERT/TERT↓, STAT3↓, TumCCA↑, Hif1a↓,
TumMeta↓, OS↑, TumCP↓, mtDam↑, Apoptosis↑, BACH1↑, eff↓, ChemoSen↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
HS587T |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
AntiTum↑, tumCV↓, selectivity↑, TumCCA↑, cycD1/CCND1↓, CDK4↓, cycE/CCNE↓, CDK2↓, P21↑, p27/CDKN1B↑, Casp9↑, Casp3↑, ROS↑, mtDam↑, i-Ca+2↑, *ROS↓, *Apoptosis↓, TumCG↓,
*ROS↓, *Inflam↓, CSCs↓, ChemoSen↑, BioAv↑, ROS↑, MMP↓, mtDam↑, TumCCA↑, cycD1/CCND1↓, CDK4↓, Casp3↑, Casp9↑, Bcl-2↓, Bcl-xL↓, BAX↑, p‑STAT3↓, AMPK↑, miR-34a↑, EMT↓, HH↓, Shh↓, Gli1↓, PTCH1↓, NF-kB↓, TNF-α↓, IL6↓, Glycolysis↓, GlucoseCon↓, BioAv↓, BioAv↓, Half-Life↝,
| - |
vitro+vivo, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
BC, |
4T1 |
|
|
|
Apoptosis↑, necrosis↑, ROS↑, mtDam↑, Ca+2↑, MPT↑, MMP↓, AntiCan↑, *AntiBio↑, *Inflam↓, *antiOx↓, *neuroP↑, p‑Akt↓, DHODH↓, Diff↑, MAPK↑,
HK2↓, GlucoseCon↓, lactateProd↓, mtDam↑, ATP↓, ROS↑, PKM2↑,
ChemoSen↓, RadioS↑, Inflam↓, AntiCan↑, Dose∅, mtDam↑, Apoptosis?, OCR↓, ATP↓, ROS↑, ROS↑, LDH↓, TP53↓, Casp3↓, BAX↓, P21↓, ROS↑, eNOS↑, iNOS↑, eff↑, hTERT/TERT↓, cycD1/CCND1↓, eff↑, eff↑, eff↑, eff↑, STAT3↓, TIMP1↓, IL4↓, IL10↓, OS↑, Dose∅, ER Stress↑, ROS↑, NF-kB↓, p65↓, MMP↓, TumAuto↑, LC3II↑, p62↓, TLR4↓, mtDam↑, LDH↓, ROS↑, Glycolysis↓, HK2↓, PFK↓, PKM2↓, LDH↓, IL10↓, HDAC8↓, eff↑, eff↑, P21↑,
ROS↑, NF-kB↓, p65↓, mtDam↑, Casp9↑, Casp3↑, Apoptosis↑, eff↓,
Showing Research Papers: 1 to 10 of 10
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 10
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
DHODH↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 13,
Mitochondria & Bioenergetics(tgid=3) ⓘ
ATP↓, 2, MMP↓, 3, MPT↑, 1, mtDam↑, 11, OCR↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1, GlucoseCon↓, 2, Glycolysis↓, 2, HK2↓, 2, lactateProd↓, 1, LDH↓, 3, PFK↓, 1, PI3K/Akt↓, 1, PKM2↓, 1, PKM2↑, 1,
Cell Death(tgid=5) ⓘ
p‑Akt↓, 1, Apoptosis?, 1, Apoptosis↑, 3, BAX↓, 1, BAX↑, 2, Bcl-2↓, 2, Bcl-xL↓, 1, Casp3↓, 1, Casp3↑, 4, Casp9↑, 4, hTERT/TERT↓, 2, iNOS↑, 1, MAPK↑, 1, necrosis↑, 1, p27/CDKN1B↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
HER2/EBBR2↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 2, GRP78/BiP↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
LC3II↑, 1, p62↓, 1, TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1, TP53↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK2↓, 1, CDK4↓, 2, cycD1/CCND1↓, 3, cycE/CCNE↓, 1, P21↓, 1, P21↑, 3, TumCCA↑, 4,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CSCs↓, 1, Diff↑, 1, EMT↓, 1, Gli1↓, 1, HDAC8↓, 1, HH↓, 1, miR-34a↑, 1, PTCH1↓, 1, PTEN↑, 1, Shh↓, 1, STAT3↓, 2, p‑STAT3↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
BACH1↑, 1, Ca+2↑, 1, i-Ca+2↑, 1, TIMP1↓, 1, TumCP↓, 1, TumMeta↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
EGFR↓, 1, eNOS↑, 1, Hif1a↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IL10↓, 2, IL4↓, 1, IL6↓, 1, Inflam↓, 1, NF-kB↓, 3, p65↓, 2, TLR4↓, 1, TNF-α↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 2, BioAv↑, 1, ChemoSen↓, 1, ChemoSen↑, 2, Dose∅, 2, eff↓, 2, eff↑, 7, Half-Life↝, 1, RadioS↑, 1, selectivity↓, 1, selectivity↑, 2,
Clinical Biomarkers(tgid=22) ⓘ
EGFR↓, 1, HER2/EBBR2↓, 1, hTERT/TERT↓, 2, IL6↓, 1, LDH↓, 3, TP53↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 2, AntiTum↑, 1, OS↑, 2,
Total Targets: 98
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
AntiBio↑, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↓, 1, antiOx↑, 1, ROS↓, 2,
Cell Death(tgid=5) ⓘ
Apoptosis↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 2,
Functional Outcomes(tgid=23) ⓘ
cardioP↑, 1, neuroP↑, 2,
Total Targets: 8
Scientific Paper Hit Count for: mtDam, mitochondrial damage
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:4 Cells:% prod#:% Target#:614 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page